Bay Rivers Group Acquires 1,887 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Bay Rivers Group increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 40.0% during the fourth quarter, Holdings Channel.com reports. The firm owned 6,610 shares of the healthcare conglomerate’s stock after buying an additional 1,887 shares during the quarter. UnitedHealth Group accounts for approximately 1.6% of Bay Rivers Group’s holdings, making the stock its 23rd biggest position. Bay Rivers Group’s holdings in UnitedHealth Group were worth $3,344,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Kathleen S. Wright Associates Inc. bought a new position in shares of UnitedHealth Group in the third quarter valued at approximately $27,000. Global Wealth Strategies & Associates increased its stake in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the period. West Financial Advisors LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter worth approximately $32,000. AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth about $30,000. Finally, RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at $37,000. Institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Up 2.0 %

Shares of NYSE UNH opened at $543.41 on Tuesday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The stock has a market capitalization of $500.09 billion, a price-to-earnings ratio of 35.06, a price-to-earnings-growth ratio of 1.41 and a beta of 0.62. The firm has a 50-day moving average price of $541.04 and a 200 day moving average price of $564.79. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.83 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.74 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.55%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Wall Street Analyst Weigh In

UNH has been the topic of several research analyst reports. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research note on Friday, January 10th. KeyCorp reiterated an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Royal Bank of Canada reduced their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Finally, Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.